Summary IMPLEMENTATION OF THE JOINT RESPONSIBILITY PRINCIPLES TO THEIR HEALTH IS ONE OF THE MAINSTREAM OF NATIONAL HEALTH CARE.
2014 жыл | Шығарылым: 5 | Беттер: 8-11
ХАЛЫҚТЫҢ ӨЗ ДЕНСАУЛЫҒЫНА ОРТАҚ ЖАУАПКЕРШІЛІГІ ҰСТАНЫМЫН ЕНГІЗУ – ОТАНДЫҚ ДЕНСАУЛЫҚ САҚТАУДЫ ДАМЫТУДЫҢ БАСТЫ БАҒЫТТАРЫНЫҢ БІРІ.
2014 жыл | Шығарылым: 5 | Беттер: 8-11
ВНЕДРЕНИЕ ПРИНЦИПА СОЛИДАРНОЙ ОТВЕТСТВЕННОСТИ НАСЕЛЕНИЯ ЗА СОБСТВЕННОЕ ЗДОРОВЬЕ – ОДНО ИЗ ГЛАВНЫХ НАПРАВЛЕНИЙ РАЗВИТИЯ ОТЕЧЕСТВЕННОГО ЗДРАВООХРАНЕНИЯ.
2014 жыл | Шығарылым: 5 | Беттер: 8-11
CONCEPTUAL VISION OF REALIZATION OF THE PATIENT-CENTERED CARE STRATEGY IN NATIONAL AND WORLD HEALTH PRACTICE
This paper presents an analytical overview of patient-centered approaches to care in the national and global healthcare practice. Data analysis of the domestic and foreign literature suggests that the implementation of patient-centered care tends to increase the efficiency of care, improve outcomes of disease, and increase the degree of patient satisfaction with medical care.
Толығырақ
2014 жыл | Шығарылым: 5 | Беттер: 3-7
ОТАНДЫҚ ЖӘНЕ ӘЛЕМДІК ДЕНСАУЛЫҚ САҚТАУ ТӘЖІРИБЕСІНДЕ ПАЦИЕНТКЕ БАҒДАРЛАНҒАН МЕДИЦИНАЛЫҚ КӨМЕК СТРАТЕГИЯСЫНЫҢ ЖҮЗЕГЕ АСУЫНА ТҰЖЫРЫМДАМАЛЫҚ КӨЗҚАРАС
2014 жыл | Шығарылым: 5 | Беттер: 3-7
COMPARATIVE EVALUATION OF BLOOD COLLECTION TUBES AND EXTRACTION METHODS FOR CIRCULATING TUMOR DNA
2025 жыл | Шығарылым: 6 | Беттер: 7-13
INFLUENCE OF SEX HORMONE-BINDING GLOBULIN (SHBG) ON THE LEVEL OF FREE TESTOSTERONE FRACTION IN OLDER OVERWEIGHT MEN
2025 жыл | Шығарылым: 6 | Беттер: 14-20
GENETIC VARIANTS IN LIPID-ASSOCIATED GENES IN THE KAZAKHSTANI COHORT WITH ATHEROSCLEROSIS AND HYPERTRIGLYCERIDEMIA
2025 жыл | Шығарылым: 5 | Беттер: 7-15
CLONAL HEMATOPOIESIS WITH INDETERMINATE POTENTIAL IN TET2 AND DNMT3A AMONG KAZAKHSTANI INDIVIDUALS WITH ATHEROSCLEROTIC DISEASE
2025 жыл | Шығарылым: 5 | Беттер: 16-23
USING OF ATORIS AT FEMALES WITH ARTERIAL HYPERTENSION AND HYPERLIPIDEMIA
So, medicine Atoris is may be used as high effective lipid lowering drug for secondary prophylaxis of cardiovascular compli-cations at females with high risk of ischemic heart disease.
Толығырақ
2012 жыл | Шығарылым: 2 | Беттер: 40-42
ARTERIAL HYPERTENSION AT OLD AGE PATIENTS
Problem of arterial hypertension at old age patients is connected with it’s wide spreading and tendency to aging of popu-lation. In old age there are different risk factors and accompanying diseases, which permit to say about that group of patients are in high or very high risk of cardiovascular complications not depending on degree of increasing of blood pressure.
Толығырақ
2012 жыл | Шығарылым: 2 | Беттер: 38-40
DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE (CHF)
This lecture consist of actuality, definition, main etiological factors of chronic heart failure and diagnostic criteria. And there is medicamentous therapy and principles of surgical and electrophysiological methods of treatment of CHF in this lecture.
Толығырақ
2012 жыл | Шығарылым: 2 | Беттер: 32-37
CALCIUM CHANNELS BLOCKERS - A ROLE IN MODERN THERAPY OF CARDIOVASCULAR DISEASES: IN FOCUS – DILTIAZEM
Calcium channels blockers – group of the drugs which basic property is ability to brake a calcium current inside of smooth muscle cells through the special channels named “slow calcium channels”. Diltiazem Lannacher renders cardioprotective action with antioxidative effect, angioprotective action, antiagregant action, antiatherogenous action, nephroprotective action, cerebroprotective action.
Толығырақ
2012 жыл | Шығарылым: 2 | Беттер: 24-34
DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AT TREATMENT OF ARTERIAL HYPERTENSION: LERKAMEN
Arterial hypertension (AH) is independent risk factor of myocardial infarction, brain stroke, chronic heart failure (CHF) and hypertensive nephropathy, death from cardiovascular diseases.
Main aim of therapy of AH is maximal decreasing of risk of development of cardiovascular morbidity and mortality.
This lecture includes data about pharmacodynamics and therapeutic efficiency of dihydropyridine calcium channel blocker Lerkamen, its advantages, indications and contraindications, metabolic neutrality, organ protection.
Толығырақ
Main aim of therapy of AH is maximal decreasing of risk of development of cardiovascular morbidity and mortality.
This lecture includes data about pharmacodynamics and therapeutic efficiency of dihydropyridine calcium channel blocker Lerkamen, its advantages, indications and contraindications, metabolic neutrality, organ protection.
Толығырақ
2012 жыл | Шығарылым: 2 | Беттер: 18-24